Is a complete LUNG research report available?

No complete published report is available for Pulmonx Corporation (LUNG) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Pulmonx Corporation (LUNG)

NASDAQ: LUNG · USD

$1.61

+0.36 (+28.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LUNG analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	68M
Revenue (ttm)	87.4M
Net income (ttm)	-48.1M
EPS (ttm)	-$1.15
Shares out	42.2M
Volume	4,813,008
Beta	0.31
Price target	$3.40	+111.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 87.4M
Net income (ttm): -48.1M
EPS (ttm): -$1.15
Market cap: 68M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LUNG indicators

Market & fundamental data

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001127537
Company name	Pulmonx Corporation
Country	United States
Country code	US
Cusip	745848101
Employees	296
Employees Change	5%
Employees Change Percent	1.72
Enterprise value	$68.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	19.92
IPO Date	2020-10-01
Isin	US7458481014
Last refreshed	2026-07-31
Market cap	$68M
Market cap category	Micro-Cap
Price	$1.61
Price currency	USD
Rev Per Employee	295,412.16x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	3841
Symbol	LUNG
Website	https://pulmonx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-70.76%
EV Sales Forward	0.73x
EV/Sales	0.78x
FCF yield	-43.25%
P/B ratio	1.74x
P/S ratio	0.78x
PS Forward	0.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-52.96%
EBITDA Margin	-52.96%
Gross margin	77.06%
Gross Profit	$67.4M
Gross Profit Growth	1.84%
Gross Profit Growth Q	3.13%
Gross Profit Growth3 Y	14.69%
Gross Profit Growth5 Y	17.43%
Net Income	$-48.1M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Pretax Margin	-54.34%
Profit Margin	-55.03%
Profit Per Employee	$-162,554
ROA	-22.1
Roa5y	-18.66
ROCE	-49.09
ROE	-88.87
Roe5y	-46.85
ROIC	-26.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-47.92%
Cagr3y	-50.7%
Cagr5y	-47.51%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	-3.43x
Revenue Growth Q	-4.62x
Revenue Growth Years	7x
Revenue Growth3 Y	12.97x
Revenue Growth5 Y	15.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.67
Assets	$114.7M
Cash	$55.8M
Current Assets	$88.1M
Current Liabilities	$20.4M
Debt	$56.2M
Debt Equity	$1.43
Equity	$39.2M
Interest Coverage	-12.29
Liabilities	$75.5M
Long Term Assets	$26.6M
Long Term Liabilities	$55.1M
Net Cash	$-368,000
Net Cash By Market Cap	$-0.54
Net Debt Equity	$0.01
Tangible Book Value	$36.9M
Tangible Book Value Per Share	$0.87
WACC	5.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.32
Inventory Turnover	1.23
Net Working Capital	$13.3M
Quick ratio	3.34
Working Capital	$67.7M
Working Capital Turnover	$1.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.69%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-47.9%
200-day SMA	1.61
3Y total return	-88.02%
50-day SMA	1.42
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.01%
All Time High	69.48
All Time High Change	-97.68%
All Time High Date	2020-12-31
All Time Low	1.13
All Time Low Change	42.48%
All Time Low Date	2026-03-30
ATR	0.13
Beta	0.31
Beta1y	2.83
Beta2y	1.42
Ch YTD	-27.15
High	1.81
High52	3.39
High52 Date	2025-07-30
High52ch	-52.51%
Low	1.33
Low52	1.13
Low52 Date	2026-03-30
Low52ch	42.48%
Ma50ch	13.78%
Premarket Change Percent	12
Premarket Price	$1.4
Premarket Volume	3,251
Price vs 200-day SMA	0.06%
RSI	63.85
RSI Monthly	35.9
RSI Weekly	50.53
Sharpe ratio	-0.17x
Sortino ratio	-0.2
Total Return	-4.69%
Tr YTD	-27.15
Tr1m	21.05%
Tr1w	31.97%
Tr3m	34.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.28
Earnings Revenue Estimate	22,363,200x
Earnings Revenue Estimate Growth	-6.27x
Operating Income	$-46.3M
Operating margin	-52.96
Price target	$3.4
Price Target Change	$111

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36,970,701%
Float Percent	87.53%
Net Borrowing	1,685,000
Shares Insiders	5.87%
Shares Institutions	68.79%
Shares Out	42,237,203
Shares Qo Q	1.36%
Shares Yo Y	4.69%
Short Float	2.86%
Short Ratio	1.88
Short Shares	2.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-49.2M
Adjusted OCF	-49,008,000
Average Volume	450,340.4x
Bv Per Share	0.92
CAPEX	$-160,000
Ch1m	21.05
Ch1w	31.97
Ch1y	-47.9
Ch3m	34.17
Ch3y	-88.02
Ch5y	-96.01
Ch6m	-6.4
Change	28.8%
Change From Open	15
Close	1.25
Days Gap	12
Depreciation Amortization	717,000
Dollar Volume	7,748,942.9
Earnings Date	2026-07-29
Earnings Time	amc
EBIT	$-46.3M
EBITDA	$-46.3M
EPS	$-1.15
F Score	3
FCF	$-29.4M
FCF EV Yield	-43.02x
FCF Per Share	$-0.7
Financing CF	2,195,000
Fiscal Year End	December
Founded	1,995
Goodwill	2,333,000
Income Tax	$596,000
Investing CF	14,160,000
Ipr	-91.53
Iprfo	-95.98
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-29
Last Report Date	2026-06-30
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	1.53
Ma150ch	5.57%
Ma20	1.38
Ma20ch	16.5%
Net CF	-12,983,000
Next Earnings Date	2026-10-28
Open	1.4
Optionable	Yes
Position In Range	58.76
Post Close	1.61
Postmarket Change Percent	0.62
Postmarket Price	$1.62
Ppne	19,152,000
Pre Close	1.25
Price Date	2026-07-30
Ptbv Ratio	1.84
Relative Volume	10.69x
Revenue	87,442,000x
SBC By Revenue	22.31x
Share Based Comp	19,757,000
Tax By Revenue	0.68x
Tr6m	-6.4%
Us State	California
Views	567
Volume	4,813,008
Z Score	-5.94

Pulmonx Corporation (LUNG)

Coverage state: Market snapshot only — no published research

Generate the first LUNG analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LUNG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LUNG indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LUNG

Frequently asked questions